Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Advances in Experimental Medicine and Biology
|
July 2, 2025
Iron and Cell Death
Giorgia Federico, Marialuisa Moccia, Francesca Carlomagno
Endocrine-Related Cancer
|
October 16, 2024
Mechanisms of RET-mediated signal transduction
Francesca Carlomagno, Marialuisa Moccia, Giorgia Federico, et al.
Genes
|
April 25, 2020
RET Gene Fusions in Malignancies of the Thyroid and Other Tissues
Massimo Santoro, Marialuisa Moccia, Giorgia Federico, et al.
European Journal of Medicinal Chemistry
|
September 19, 2014
Identification of two novel RET kinase inhibitors through MCR-based drug discovery: design, synthesis and evaluation
Brendan Frett, Marialuisa Moccia, Francesca Carlomagno, et al.
Scientific Reports
|
November 25, 2025
Discovery of a Proteolysis Targeting Chimera for TRKA and RET-derived oncoproteins
Marialuisa Moccia, Lingzhi Zhang, Zhengyu Wang, et al.
European Journal of Medicinal Chemistry
|
March 2, 2021
Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation
Wei Yan, Lingtian Zhang, Fengping Lv, et al.
Scientific Reports
|
May 23, 2025
Ultrasound-induced mechanical damage of cancer cell cytoskeleton causes disruption of nuclear envelope and activation of cGAS-STING
Giorgia Federico, Angelo Rosario Carotenuto, Arsenio Cutolo, et al.
JCO Precision Oncology
|
August 3, 2023
D898_E901 <i>RET</i> Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms
Tommaso Porcelli, Marialuisa Moccia, Maria Angela De Stefano, et al.
Scientific Reports
|
August 10, 2021
Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases
Marialuisa Moccia, Donglin Yang, Naga Rajiv Lakkaniga, et al.
Journal of Medicinal Chemistry
|
April 17, 2020
Bioisosteric Discovery of NPA101.3, a Second-Generation RET/VEGFR2 Inhibitor Optimized for Single-Agent Polypharmacology
Marialuisa Moccia, Brendan Frett, Lingtian Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Advances in Experimental Medicine and Biology
|
July 2, 2025
Iron and Cell Death
Giorgia Federico, Marialuisa Moccia, Francesca Carlomagno
Endocrine-Related Cancer
|
October 16, 2024
Mechanisms of RET-mediated signal transduction
Francesca Carlomagno, Marialuisa Moccia, Giorgia Federico, et al.
Genes
|
April 25, 2020
RET Gene Fusions in Malignancies of the Thyroid and Other Tissues
Massimo Santoro, Marialuisa Moccia, Giorgia Federico, et al.
European Journal of Medicinal Chemistry
|
September 19, 2014
Identification of two novel RET kinase inhibitors through MCR-based drug discovery: design, synthesis and evaluation
Brendan Frett, Marialuisa Moccia, Francesca Carlomagno, et al.
Scientific Reports
|
November 25, 2025
Discovery of a Proteolysis Targeting Chimera for TRKA and RET-derived oncoproteins
Marialuisa Moccia, Lingzhi Zhang, Zhengyu Wang, et al.
European Journal of Medicinal Chemistry
|
March 2, 2021
Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation
Wei Yan, Lingtian Zhang, Fengping Lv, et al.
Scientific Reports
|
May 23, 2025
Ultrasound-induced mechanical damage of cancer cell cytoskeleton causes disruption of nuclear envelope and activation of cGAS-STING
Giorgia Federico, Angelo Rosario Carotenuto, Arsenio Cutolo, et al.
JCO Precision Oncology
|
August 3, 2023
D898_E901 <i>RET</i> Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms
Tommaso Porcelli, Marialuisa Moccia, Maria Angela De Stefano, et al.
Scientific Reports
|
August 10, 2021
Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases
Marialuisa Moccia, Donglin Yang, Naga Rajiv Lakkaniga, et al.
Journal of Medicinal Chemistry
|
April 17, 2020
Bioisosteric Discovery of NPA101.3, a Second-Generation RET/VEGFR2 Inhibitor Optimized for Single-Agent Polypharmacology
Marialuisa Moccia, Brendan Frett, Lingtian Zhang, et al.
Page
of 2